Company Search:
Advanced Search
Sponsored Links
Krka DD Novo Mesto Company Snapshot
Krka DD Novo Mesto operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Krka DD Novo Mesto with three other pharmaceutical manufacturers in Europe: Recordati SpA of Italy (2016 sales of 1.15 billion Euro [US$1.25 billion] of which 84% was Pharmaceuticals), Orion Oyj of Finland (1.07 billion Euro [US$1.16 billion] of which 95% was Pharmaceuticals Business), and Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag which is based in Hungary (389.69 billion Hungarian Forints [US$1.36 billion] ).

Sales Analysis. Krka DD Novo Mesto reported sales of 1.17 billion Euro (US$1.27 billion) for the year ending December of 2016. This represents a very small increase of 0.8% versus 2015, when the company's sales were 1.16 billion Euro. Despite this increase, sales are still slightly below the level achieved in 2014, when Krka DD Novo Mesto reported sales of 1.19 billion Euro. The sales level in 2016 was fairly close to the level five years ago: in 2011, Krka DD Novo Mesto had sales of 1.08 billion Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Krka DD Novo Mesto
  Stock Performance Chart for Krka DD Novo Mesto
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 53.00
(Figures in Euro)
1 Week 0.0%   13 Weeks 2.9%  
4 Weeks 3.9%   52 Weeks -13.3%  
Krka DD Novo Mesto Key Data:
  Ticker: KRKG Country: Slovenia
  Exchanges: LJB Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,174,424,000
(Year Ending Jan 2017).
Employees: 10,564
  Currency: Euro Market Cap: 1,711,916,854
  Fiscal Yr Ends: December Shares Outstanding: 32,300,318
  Share Type: Ordinary Closely Held Shares: 6,479,863
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.